The relation of smoking to the occurrence of the most common types of lung cancer has been examined and found positive in epidemiological studies. Types that have been causally ascribed to smoking in such studies have included squamous cell, small and large cell, and adenocarcinomas (US Dept of Health & Human Services, 1982 ; International Agency for Research on Cancer, 1986) . However, rarer types, such as giant and alveolar cell carcinomas, have not been subject to separate study, not only because of their rarity, but because some pathologic classification systems for lung cancer include these types with other histologies (Yesner & Carter, 1982) . While all histological types of lung cancer studied thus far have been related to tobacco use and no type has yet been found to be unrelated, there have been questions raised about the relationship of smoking to these rarer types.
Giant cell carcinoma of the lung was first described by Nash and Stout in 1958 . Some investigators classify it as a separate entity (Shin et al., 1986) . On the other hand, some have included it as a sub-type of adenocarcinoma of the lung, while both the World Health Organization and the Armed Forces Institute of Pathology include it with large cell undifferentiated carcinoma (Razzuk el al., 1970) . These several schemes lead to non-uniform criteria in the literature for diagnosis of pulmonary giant cell carcinoma. A survey such as ours cannot resolve this difficulty and, therefore, we must accept the cases reported as genuine for our purpose.
This survey is an attempt to provide some information bearing on the aetiological relationship of giant cell carcinoma of the lung to smoking. We searched the literature, as indexed by Medline through 1986, for case reports of pulmonary giant cell carcinoma which included smoking histories.
We found reports of 119 cases of pulmonary giant cell carcinoma with smoking histories of the patients. Only eight of these cases were female, five smokers and three nonsmokers, which are too few to analyse separately. Therefore, we confined our analysis to males. The 111 male cases with smoking data were found in 23 independent studies (Bendel & Ishak, 1961; Broderick et al., 1975; Dailey & Marcuse, 1969; DeAngelis et al., 1961; Flanagan & Roeckel, 1964; Friedberg, 1965; Gajaraj et al., 1971; Guillan & Zelman, 1966; Hathaway et al., 1969; Hellstrom & Fisher, 1963; Horie & Ohta, 1981; Kallenberg & Jaque, 1979; Kennedy, 1969; Lerner, 1967; Naib, 1961; Matsuo et al., 1986; Nash & Stout, 1958; Pfeffer & Stoven, 1978; Pfitzer & Knoblich, 1975; Shin et al., 1986; Thomas, 1962; Wang et al., 1976) . (Although not reported as such in the publication, one woman in the study of Shin et al. (1986) was a smoker, as were 8 of the 13 men; Shin, personal communication.) We also found 99 other cases, 81 male and 18 female, in other studies which did not contain smoking information (12 references not cited). Therefore, the male: female sex ratio for pulmonary giant cell carcinoma is 7.4:1.
Of the 111 men with giant cell carcinoma of the lung, only eight (7.2%) had been non-smokers. This 0.93 proportion of smokers among men with giant cell carcinoma of the lung has a 95% confidence interval of 0.86-0.96 (Rothman & Boice, 1979) . This confidence interval does not come near to overlapping any of the estimates of the prevalence of smoking among US males and, therefore, is highly statistically significant (Table I) Cancer, 1986) . Our use of US smoking prevalence for the years 1965-1980 as a population comparison is jsutified by the fact that the reports we used were from 1958 to 1986, essentially the same period, and that 83% of our reported cases were from the US.
There is a possibility that the authors of the case histories may have mentioned a positive history of smoking more readily than a negative one. This bias cannot be completely excluded. However, in order to have the 95% confidence limits (Rothman & Boice, 1979) of our observed proportion overlap the expected 71% prevalence of a positive history of smoking, at least 20 non-smokers must have been unreported. This would mean that the non-smokers would have to have been at least 70% under-reported for our result to become non-significant, which is an unreasonably high proportion.
In summary, we abstracted smoking data from 23 published clinical reports of giant cell carcinoma of the lung in 111 men, of whom 93% were or had been smokers. This proportion is significantly higher than the 71% prevelance of a history of smoking among US men in the corresponding 
